EUCTR2007-001987-55-SE进行中（未招募）1 期
Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer: A randomised trial assessing whether preoperative chemotherapy and/or an anti-EGFR monoclonal antibody improve outcome in high-risk operable colon cancer - FOxTROT
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Histologically proven colon cancer with a radiological staging of greater than or equal to T3, NX, M0.
- •2.Patients who have been fully staged radiologically by CT scanning and are poor prognosis (ref to protocol for further info).
- •3.Fit for the neoadjuvant treatments; (details in protocol)
- •4.Patients who have presented with acute colonic obstruction may enter the trial only if a successful defunctioning or stent procedure has been performed.
- •5.Patients able and willing to provide written informed consent for the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients with evidence of disseminated disease.
- •2. Patients with tumour with rectal cancer
- •3. Patients with peritonitis (secondary to perforated tumour)
- •4. Patients with obstruction, who are not defunctioned or stented.
- •5. Patients unable to give informed consent.
- •6. Patients with serious medical comorbidity
- •7. Patients with an indication for radiotherapy
- •8. Patients under the age of 18 or pregnant.
研究者
相似试验
进行中（未招募）
1 期
Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer: A randomised trial assessing whether preoperative chemotherapy and/or an anti-EGFR monoclonal antibody improve outcome in high-risk operable colon cancer - FOxTROTPatients with high-risk, operable colon cancerMedDRA version: 14.1Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009956Term: Colon cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-001987-55-DKniversity Of Birmingham150
进行中（未招募）
1 期
A trial looking at chemotherapy and panitumumab before and after surgery for bowel cancer (FOxTROT)Patients with high-risk, operable colon cancerMedDRA version: 19.0Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10009956Term: Colon cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-001987-55-GBniversity Of Birmingham1,050
已完成
2 期
Fluoropyrimidine, oxaliplatin and targeted receptor pre-operative therapy: a controlled trial in high-risk operable colon cancerHigh risk, operable colon cancerColon cancerCancerISRCTN87163246niversity of Birmingham (UK)1,050
招募中
2 期
Fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in non-resectable pancreatic cancer patients.Pancreatic cancerJPRN-UMIN000005808Yokohama City University Graduate School of Medicine60
Unknown
2 期
Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by SurgeryColorectal CancerNCT00647530University of Birmingham1,053